Serotonin Norepinephrine Reuptake Inhibitor Is Associated With Lower Mortality Among Patients Presenting With Takotsubo Cardiomyopathy

Background Serotonin–norepinephrine reuptake inhibitors (SNRIs) inhibit the presynaptic reuptake of serotonin and norepinephrine and are widely used in the treatment of depression and neuropathic pain. We evaluate the impact of SNRIs use on the clinical outcomes of patients presenting with Takotsubo...

詳細記述

書誌詳細

主要な著者:	Garba Rimamskep Shamaki, Anderson Anuforo, Israel Safiriyu, David Corteville, Monika Sanghavi, Samit Shah, Katherine Clark
フォーマット:	Artigo
言語:	Inglês
出版事項:	Wiley 2025-07-01
シリーズ:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
主題:	antidepressants cardiomyopathy depression mortality serotonin–norepinephrine reuptake inhibitors (SNRIs) Takotsubo cardiomyopathy
オンライン･アクセス:	https://www.ahajournals.org/doi/10.1161/JAHA.124.037951
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!